We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
NBA, US funds/Xinjiang, Royal Philips, LVMH, Domino’s Pizza and more
There is no reason for Switzerland to cut borrowing costs further
LSE/HKEX, Peloton, Cairn/climate change, BAT/vaping, Uber/Lyft
Philip Morris/Altria, Purdue, Swatch/Richemont, Fanuc, Petrofac, UBS, Pets at Home and more
Uber, Lyft, Bayer, Thyssenkrupp, Deutsche Post, Scout24, Aviva, US/China and more
With the disastrous purchase of Monsanto and plummeting shares, some question if it is time to break up the German group
UK equities, Deutsche Bank, European banks, oil tankers, Aston Martin, GSK, Facebook
A scan of the city skyline reminds visitors of challenges facing would-be national champion
Neil Woodford, UK biotech, Renault/FCA, Refinitiv, Blackstone, Amazon, Dignity, Tiffany
Uber, FCA/Renault/Nissan, De La Rue, ECB, Alibaba, rare earths, iron ore and more
Beiersdorf, Lloyds, PMI, Sainsbury’s, Bayer, Uber, Danske/Nordic banking
Tobacco/Scott Gottlieb, Schroders, Aviva/Maurice Tulloch, Relx/librarians and more
PSA, Zalando, Barclays, Hyundai, Swedbank, EY, Metro Bank, Weight Watchers and more
Kraft Heinz, Danone v Nestlé, Sainsbury’s/antitrust, Centrica, Wirecard, Tesla and more
Dyson, Airbus, StanChart, UBS, BuzzFeed, Hugo Boss, Big Four auditors
Staff who report wrongdoing risk losing their jobs or even criminal prosecution
Tough talk on migration has boosted centre-right but critics say chancellor legitimises extremist ideas
Some will be ‘disappointed’ as alternative capital sector comes under strain
Initiative has US approval and rivals EU plan to bypass sanctions
Group that supplies robots to Jaguar Land Rover says manufacturing hit would be ‘sad’
EU says Switzerland’s ‘equivalence’ deal allows access to bloc without following its rules
Deal is largest overseas purchase by Japanese group as it looks to become global powerhouse
Pharma group explores routes to finance ‘curative’ treatments for once-fatal diseases
Swiss bank pledges to buy back as much as SFr3bn of its shares over two years
International Edition
